Prosecution Insights
Last updated: July 17, 2026
Application No. 18/274,042

EPOXIDATION CATALYST

Final Rejection §103
Filed
Jul 25, 2023
Priority
Jan 26, 2021 — EU 21153364.1 +1 more
Examiner
SHERMAN, ERIC SCOTT
Art Unit
1736
Tech Center
1700 — Chemical & Materials Engineering
Assignee
BASF SE
OA Round
2 (Final)
72%
Grant Probability
Favorable
3-4
OA Rounds
4m
Est. Remaining
87%
With Interview

Examiner Intelligence

Grants 72% — above average
72%
Career Allowance Rate
65 granted / 90 resolved
+7.2% vs TC avg
Moderate +15% lift
Without
With
+14.6%
Interview Lift
resolved cases with interview
Typical timeline
3y 4m
Avg Prosecution
35 currently pending
Career history
124
Total Applications
across all art units

Statute-Specific Performance

§101
1.7%
-38.3% vs TC avg
§103
65.4%
+25.4% vs TC avg
§102
11.7%
-28.3% vs TC avg
§112
9.6%
-30.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 90 resolved cases

Office Action

§103
DETAILED ACTION Claims 14-26 are pending, of which claims 25-26 have been withdrawn. Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Response to Arguments Applicant's arguments filed 5/8/26 have been fully considered but they are not persuasive. On pages 2-5, Applicant argues that providing a catalyst having the recited amount of rhenium unexpectedly improves selectivity. Applicant points to a comparison of catalyst 1-8 with catalyst 1-11. Catalyst 1-8, which has a higher rhenium content and lower tungsten content than catalyst 1-11, provides a selectivity of 87.8%, while catalyst 1-11 has a selectivity of 85.4%. Applicant also points out that the catalyst 1-7, which has a cRe + (2 X cW) lower than that of catalyst 1-8, has a selectivity of 83.3%. Applicant concludes that these results unexpectedly show that the amount of rhenium and tungsten plays a significant role in selectivity. Examiner agrees that the amount of rhenium and tungsten included in the catalyst has an effect on the selectivity. However, it is unclear why this would be unexpected. Karpov explicitly teaches that rhenium increases selectivity of the catalyst, and that selectivity is an important factor in choosing a catalyst (see e.g. page 1, lines 18-22). Although Applicant has shown some improvement in selectivity by increasing the amount of rhenium used, Applicant has not shown that this increase is in any way greater than would have been expected based on the known property that rhenium increases selectivity for similar catalysts. Additionally, the data provided by Karpov tends to show that increasing the rhenium and tungsten content of the catalyst results in increased selectivity. For example, catalyst 3.3.4 of Karpov, which has the highest rhenium and tungsten contents of those tested, has a higher selectivity than similar catalysts with less rhenium and tungsten (see e.g. Tables 6 and 8). The only difference between catalyst 3.3.2 and catalyst 3.3.4 of Karpov is the amount of rhenium, and increasing the rhenium amount results in increasing selectivity (Id.). Similarly, the only difference between catalyst 3.3.1 and catalyst 3.3.6 is the amount of tungsten, and increasing the amount of tungsten increases the selectivity of the catalyst (Id.). Accordingly, based on the teachings of Karpov, one of ordinary skill in the art would understand that higher rhenium and tungsten contents result in a more selective catalyst. A person of ordinary skill in the art would therefore be motivated to use rhenium and tungsten values towards the higher end of the ranges provided by Karpov, resulting in a catalyst that meets the claimed limitations. Further, the claimed amount of rhenium is not simply the far upper end of a large range taught by Karpov. Rather, the claimed amount overlaps with a narrow “particularly preferred” range of Karpov (see e.g. page 5, lines 5-10). Given that rhenium was known to affect selectivity, and given that the most narrow disclosed range in Karpov overlaps with the claimed range, it would have been obvious to one of ordinary skill in the art to use a rhenium content at the higher end of Karpov’s “particularly preferred” range. As described in the prior office actions and in the rejections below, when using a rhenium content within this range, the vast majority of the possible catalysts disclosed in Karpov would meet the cRe + (2 X cW) limitation. On page 7, Applicant argues that the highest value for cRe + (2 X cW) for any specific example of Karpov is 12.06. Examiner agrees that the specific examples in Karpov do not meet each claim limitation simultaneously. However, given that the ranges disclosed in Karpov overlap with the claimed ranges for each and every component of the catalyst, and given that the data provided in Karpov shows that increasing rhenium and tungsten increases the selectivity of the catalyst, it would have been obvious to one of ordinary skill in the art to choose values from the narrow taught ranges of Karpov to optimize selectivity, which would result in the claimed catalyst composition. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 14-24 is/are rejected under 35 U.S.C. 103 as being unpatentable over WO 2019154832 (“Karpov”). Regarding claim 14, Karpov teaches an epoxidation catalyst that comprises silver, cesium, rhenium, and tungsten on an alumina support (see e.g. page 4, lines 11-22). Karpov teaches that the silver content is 20-45% by weight, which is entirely within the claimed range (see e.g. page 4, lines 11-14). Karpov teaches that the cesium content is preferably between 4.5-11.3 mmol/kg, which overlaps with the claimed range (see e.g. page 4, line 36 to page 5, line 3 and claim 5). Karpov teaches that the rhenium content is between 3-9 mmol/kg, which overlaps with the claimed range (see e.g. page 5, lines 5-9 and claim 5). The tungsten content of the catalyst is between 1.6-5.5 mmol/kg (see e.g. page 5, lines 11-16 and claim 5). For embodiments with the rhenium content within the claimed range, the value of cRe + (2 X cW) is therefore between 9.9-20, the majority of which is within the claimed range. Given that Karpov teaches that increasing rhenium increases selectivity, it would have been obvious for one of ordinary skill in the art to use a rhenium content at the higher end of the disclosed range. Per MPEP 2144.05(I), in the case where the claimed ranges overlap or lie inside ranges disclosed by the prior art a prima facie case of obviousness exists. Although the specific catalysts made in Karpov do not simultaneously meet each and every limitation, given the overlap of ranges claimed for every component, the claimed catalyst composition is obvious over that of Karpov. Regarding claim 15, Karpov teaches that the tungsten content of the catalyst is between 1.6-5.5 mmol/kg, the majority of which overlaps with the claimed range (see e.g. page 5, lines 11-16 and claim 5). Regarding claim 16, Karpov teaches that the rhenium content is between 3-9 mmol/kg, which overlaps with the claimed range (see e.g. page 5, lines 5-9 and claim 5). Regarding claim 17, Karpov teaches that the tungsten content of the catalyst is between 1.6-5.5 mmol/kg, which overlaps with and includes the entirety of the claimed range (see e.g. page 5, lines 11-16 and claim 5). Regarding claim 18, Karpov teaches that the cesium content is preferably between 4.5-11.3 mmol/kg, which overlaps with the claimed range (see e.g. page 4, line 36 to page 5, line 3 and claim 5). Regarding claim 19, Karpov teaches that the catalyst comprises lithium in a preferable amount of between 55-80 mmol/kg, which is within the claimed range (see e.g. page 6, lines 16-18). Regarding claim 20, Karpov teaches that the catalyst comprises sulfur in an amount of 0.6-15 mmol/kg, which is within the claimed range (see e.g. page 6, lines 24-26). Regarding claim 21, Karpov teaches that the catalyst preferably comprises 3.5-6.4 mmol/kg of potassium, which is within the claimed range (see e.g. page 5, lines 35-37). Regarding claim 22, Karpov teaches that the catalyst is supported on alpha-alumina and does not mention any other phase of alumina (see e.g. page 15, lines 6-11). Accordingly, one of skill in the art would understand that Karpov uses more than 80% alpha-alumina. Regarding claim 23, Karpov teaches that the surface area of the catalyst is 1.5-2.5 m2/g, nearly the entirety of which is within the claimed range (see e.g. page 8, lines 28-31). Regarding claim 24, Karpov does not provide the exact pore volume of the catalyst. However, Karpov teaches that the water absorption of the catalyst is 0.35-0.70 ml/g (see e.g. page 8, lines 33-35). Given this water absorption, one of ordinary skill in the art would understand that the total pore volume is likely within the claimed range. Conclusion THIS ACTION IS MADE FINAL. Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to ERIC S SHERMAN whose telephone number is (703)756-4784. The examiner can normally be reached Monday-Friday 8:30-5:00 ET. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Anthony Zimmer can be reached at (571)270-3591. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /E.S.S./Examiner, Art Unit 1736 /ANTHONY J ZIMMER/Supervisory Patent Examiner, Art Unit 1736
Read full office action

Prosecution Timeline

Jul 25, 2023
Application Filed
Feb 13, 2026
Non-Final Rejection mailed — §103
May 08, 2026
Response Filed
Jul 02, 2026
Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12671122
FLUIDIZED BED REACTOR AND METHOD FOR RECOVERING ACTIVE METAL OF LITHIUM SECONDARY BATTERY USING SAME
3y 10m to grant Granted Jun 30, 2026
Patent 12668496
Methods and Apparatuses for Making Nanomaterials in Space
3y 5m to grant Granted Jun 30, 2026
Patent 12665100
URANIUM HEXAFLUORIDE BYPRODUCTS AND/OR MATERIALS DISPOSAL
3y 10m to grant Granted Jun 23, 2026
Patent 12662397
COMPOUNDS AND PROCESSES FOR REMEDIATION OF PERFLUOROALKYL SUBSTANCES
3y 1m to grant Granted Jun 23, 2026
Patent 12661639
INORGANIC COMPOUND, DISPERSION AND METHOD FOR PRODUCING SAME, AND FILM AND METHOD FOR PRODUCING SAME, INORGANIC COMPOUND, METHOD FOR PRODUCING METHANE AND HYDROGEN, DISPERSION AND METHOD FOR PRODUCING SAME, AND FILM AND METHOD FOR PRODUCING SAME
1y 4m to grant Granted Jun 23, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
72%
Grant Probability
87%
With Interview (+14.6%)
3y 4m (~4m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 90 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month